At a glance
- Originator Chugai Pharmaceutical
- Class Class Ib antiarrhythmics
- Mechanism of Action Calcium channel antagonists; Potassium channel antagonists; Sodium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Arrhythmias
Most Recent Events
- 23 Jun 1995 Discontinued-Preclinical for Arrhythmias in Japan (PO)